Overall, this suggests that the cumulative risk of breast cancer before age 55 for women taking estrogen/progestin is about 4 ...

A groundbreaking study by the National Institutes of Health (NIH) is shifting the conversation around hormone therapy and breast cancer risk in women under 55. By analyzing data from nearly half a ...

The study, published Tuesday in The Lancet Oncology, focused on women under 55 with and without a uterus. CBS News medical ...

Associations between hormone therapy and young-onset breast cancer (diagnosed at younger than 55 years) vary, according to a study published online in the July issue of The Lancet Oncology.

The relationship between hormone therapy (oestrogen with or without progestogen) and breast cancer risk has been widely ...

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...

However, long-term use (>2 years) of estrogen/progestin hormone therapy was positively associated with young-­onset breast ...

Dr. Alicia Arnold and Dr. Priyanka Raval discuss first- and later-line treatment options for those with ER-positive, ...

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast ...

An international team of researchers wanted to explore the risks among younger women on hormone therapy. Here’s what they ...